Authors

• John D. Davis (ORCID: https://orcid.org/0000-0001-6282-1670)
• Ching‐Ha Lai
• Ned Braunstein
• Ainara Rodríguez-Marco
• Jennifer Maloney
• Marius Ardeleanu (ORCID: https://orcid.org/0000-0002-7712-6862)
• Manoj Rajadhyaksha
• Albert Torri
• Eric Mortensen
• Brad Shumel (ORCID: https://orcid.org/0000-0002-9285-8164)
• Christine Xu
• Matthew P. Kosloski (ORCID: https://orcid.org/0000-0002-6642-2439)
• Bolanle Akinlade (ORCID: https://orcid.org/0000-0003-2334-5717)
• Guy Gherardi
• Vanaja Kanamaluru
• Neil Stahl (ORCID: https://orcid.org/0000-0001-7265-2575)
• Ashish Bansal (ORCID: https://orcid.org/0000-0002-7371-6486)
• Jing Xiao
• Hong Yan (ORCID: https://orcid.org/0000-0001-9661-3095)
• Michael A. Partridge (ORCID: https://orcid.org/0000-0001-6699-8473)
• Mohamed Kamal
• Arsalan Shabbir (ORCID: https://orcid.org/0009-0007-8720-4151)
• Susan Richards (ORCID: https://orcid.org/0000-0002-8288-5636)
• A. Thomas DiCioccio
• Faisal A. Khokhar
• Elisa Babilonia

Institutions

• Regeneron (United States) (US)
• Sanofi (Spain) (ES)
• Sanofi (United States) (US)
• Sanofi (United Kingdom) (GB)

Publication Details

Journal

Frontiers in Immunology

Published

2024-11-11

DOI

https://doi.org/10.3389/fimmu.2024.1466372

Citations

7

Primary Topic

Dermatology and Skin Diseases

Type

article

Field-Weighted Citation Impact

3.74

Funders

• Sanofi
• Regeneron Pharmaceuticals